This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Ingelsson, E. Articles by Lind, L. Search for Related Content PubMed PubMed Citation Articles by Ingelsson, E. Articles by Lind, L.

CLINICAL RESEARCH: HEART FAILURE

Inflammation, as Measured by the Erythrocyte Sedimentation Rate, Is an Independent Predictor for the Development of Heart Failure

Erik Ingelsson, MD^_*,_*, Johan Ärnlöv, MD, PhD^_*, Johan Sundström, MD, PhD^_* and Lars Lind, MD, PhD^,

^_* Public Health and Caring Sciences, Uppsala, Sweden
Medical Sciences, Uppsala University, Uppsala, Sweden
Astra Zeneca R & D, Mölndal, Sweden

Manuscript received December 14, 2004; revised manuscript received February 16, 2005, accepted February 22, 2005.

^_* Reprint requests and correspondence: Dr. Erik Ingelsson, Department of Public Health and Caring Sciences, Section of Geriatrics, Uppsala University, Box 609, SE-75125 Uppsala, Sweden. (Email: erik.ingelsson{at}pubcare.uu.se).

OBJECTIVES: Our objective was to explore inflammation, measured as erythrocyte sedimentation rate (ESR), as a predictor for the development of heart failure (HF).

BACKGROUND: In recent years, evidence of the importance of inflammation in the pathophysiology of HF has emerged, and various inflammatory markers have been found to predict future HF. Erythrocyte sedimentation rate is an inexpensive and easily accessible marker of systemic inflammation, but to this date it is unknown whether ESR predicts subsequent HF.

METHODS: In a community-based prospective study of 2,314 middle-aged men free from HF, myocardial infarction, and valvular disease at baseline, ESR was analyzed in multivariable models together with established risk factors for HF (hypertension, diabetes, electrocardiographic left ventricular hypertrophy, smoking, obesity, and serum cholesterol) and hematocrit.

RESULTS: A total of 282 men developed HF during a median follow-up time of 30 years. In Cox proportional hazards analyses, ESR was an independent predictor of HF (hazard ratio 1.46 for highest quartile vs. the lowest, 95% confidence interval 1.04 to 2.06). This observation remained significant when also adjusting for interim myocardial infarction during follow-up.

CONCLUSIONS: Erythrocyte sedimentation rate was a significant predictor of HF, independent of established risk factors for HF, and interim myocardial infarction after three decades of follow-up in a population-based sample of middle-aged men. Our findings indicate that inflammation occurs early in the process leading to HF and that ESR could be used to evaluate this process.

Abbreviations and Acronyms   BMI = body mass index   CI = confidence interval   ESR = erythrocyte sedimentation rate   HF = heart failure   HR = hazard ratio   ICD = International Classification of Diseases   IL = interleukin   TNF = tumor necrosis factor   ULSAM = Uppsala Longitudinal Study of Adult Men

This article has been cited by other articles:

				G. Engstrom, O. Melander, and B. Hedblad Carotid Intima-Media Thickness, Systemic Inflammation, and Incidence of Heart Failure Hospitalizations Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1691 - 1695. [Abstract] [Full Text] [PDF]

				G. Engstrom, O. Melander, and B. Hedblad Leukocyte Count and Incidence of Hospitalizations Due to Heart Failure Circ Heart Fail, May 1, 2009; 2(3): 217 - 222. [Abstract] [Full Text] [PDF]

				E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]

				E. Ingelsson, L. Lind, J. Arnlov, and J. Sundstrom Sleep disturbances independently predict heart failure in overweight middle-aged men Eur J Heart Fail, February 1, 2007; 9(2): 184 - 190. [Abstract] [Full Text] [PDF]

				T.-J. Wu, H.-Y. Ou, C.-W. Chou, S.-H. Hsiao, C.-Y. Lin, and P. C. Kao Decrease in Inflammatory Cardiovascular Risk Markers in Hyperlipidemic Diabetic Patients Treated with Fenofibrate Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 158 - 166. [Abstract] [Full Text] [PDF]

				E Ingelsson, J Arnlov, L Lind, and J Sundstrom Metabolic syndrome and risk for heart failure in middle-aged men Heart, October 1, 2006; 92(10): 1409 - 1413. [Abstract] [Full Text] [PDF]

				E. Ingelsson, J. Arnlov, J. Sundstrom, B. Zethelius, B. Vessby, and L. Lind Novel Metabolic Risk Factors for Heart Failure J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2054 - 2060. [Abstract] [Full Text] [PDF]